Upstream Bio, Inc. UPB Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $1.03M+54.8% | $668K-2.2% | $683K-27.1% | $937K+65.5% | $566K-7.7% | ||
| $36.57M-9.0% | $40.17M+21.8% | $32.98M-12.9% | $37.87M+46.8% | $25.8M+18.5% | ||
| $8.08M+21.3% | $6.67M+20.3% | $5.54M-25.3% | $7.42M+9.4% | $6.78M+31.5% | ||
| $44.65M-4.7% | $46.84M+21.6% | $38.52M-14.9% | $45.28M+39.0% | $32.58M+21.0% | ||
| $44.65M-4.7% | $46.84M+21.6% | $38.52M-14.9% | $45.28M+39.0% | $32.58M+21.0% | ||
| -$43.62M+5.5% | -$46.17M-22.0% | -$37.83M+14.7% | -$44.35M-38.5% | -$32.01M-21.6% | ||
| -4,218.1%+2,693pp | -6,911.2%-1,372pp | -5,539.4%-807pp | -4,732.9%+923pp | -5,656%-1,363pp | ||
| $3.05M-16.4% | $3.65M-11.0% | $4.11M-7.4% | $4.43M-6.6% | $4.74M-6.6% | ||
| $3.02M-18.4% | $3.71M-9.3% | $4.09M-6.7% | $4.38M-7.6% | $4.74M-6.6% | ||
| -$40.59M+4.4% | -$42.46M-25.8% | -$33.75M+15.6% | -$39.97M-46.6% | -$27.27M-28.4% | ||
| -3,925.6%+2,431pp | -6,356.1%-1,415pp | -4,941.1%-676pp | -4,265.3%+553pp | -4,818%-1,353pp | ||
| -$0.75+3.8% | -$0.78-23.8% | -$0.63+14.9% | -$0.74-45.1% | -$0.51— | ||
| -$0.75+3.8% | -$0.78-23.8% | -$0.63+14.9% | -$0.74-45.1% | -$0.51— | ||
| 54.3M+0.9% | 53.9M-0.1% | 53.9M+0.3% | 53.8M+0.3% | 53.6M+292% | ||
| 54.3M+0.9% | 53.9M-0.1% | 53.9M+0.3% | 53.8M+0.3% | 53.6M+292% | ||
| -$41.02M+3.3% | -$42.42M-26.6% | -$33.51M+16.4% | -$40.08M-49.1% | -$26.88M-24.3% | ||
| -$430K-1,262% | $37K-84.3% | $235K+314% | -$110K-128% | $393K+205% | ||
| -$30K— | —— | -$19K+62.0% | -$50K— | $0— | ||
| $1.03M+54.8% | $668K-2.2% | $683K-27.1% | $937K+65.5% | $566K-7.7% | ||
| -$43.62M+5.5% | -$46.17M-22.0% | -$37.83M+14.7% | -$44.35M-38.5% | -$32.01M-21.6% | ||
| -$43.57M+5.5% | -$46.11M-22.0% | -$37.79M+14.7% | -$44.31M-38.6% | -$31.97M-21.7% | ||
| -$43.57M+5.5% | -$46.11M-22.0% | -$37.79M+14.7% | -$44.31M-38.6% | -$31.97M-21.7% | ||
| -4,213.3%+2,689pp | -6,902.7%-1,370pp | -5,532.7%-804pp | -4,728.4%+920pp | -5,648.4%-1,363pp | ||
| -$43.62M+5.5% | -$46.17M-22.0% | -$37.83M+14.7% | -$44.35M-38.5% | -$32.01M-21.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Upstream Bio, Inc.'s revenue?
- Upstream Bio, Inc. (UPB) generated $3.3M in revenue over the trailing twelve months, up 44.7% year over year.
- Is Upstream Bio, Inc. profitable?
- Upstream Bio, Inc. is not currently profitable: it reported a net loss of $156.8M over the trailing twelve months, a -4719.0% net margin.
- What is Upstream Bio, Inc.'s earnings per share?
- Upstream Bio, Inc.'s diluted EPS over the trailing twelve months is $-2.90.
- Where does Upstream Bio, Inc.'s income statement data come from?
- Every line is extracted from Upstream Bio, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
